These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 3988389

  • 1. Impairment of drug elimination in patients with liver disease.
    Narang AP, Datta DV, Mathur VS.
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389
    [Abstract] [Full Text] [Related]

  • 2. Hepatic drug metabolizing capacity of patients of cirrhosis before and after clinico-biochemical recovery.
    Chauhan CK, Nanivadekar SA, Billimoria FR.
    Indian J Physiol Pharmacol; 1989 Jan; 33(1):63-6. PubMed ID: 2737749
    [Abstract] [Full Text] [Related]

  • 3. [Comparative study on the elimination of pindolol (visken) and antipyrin in patients with liver diseases].
    Ohnhaus EE, Münch U, Meier J.
    Schweiz Med Wochenschr; 1976 Dec 04; 106(49):1748-50. PubMed ID: 1013699
    [Abstract] [Full Text] [Related]

  • 4. Fractional clearance of bromosulfonephthalein and metabolic clearance of antipyrine. Correlative study in liver diseases.
    Couet C, Brissot P, Messner M, Delamaire D, Gie S, Bourel M.
    Ann Gastroenterol Hepatol (Paris); 1984 Dec 04; 20(1):1-6. PubMed ID: 6529154
    [Abstract] [Full Text] [Related]

  • 5. Comparison of quantitative methods to assess hepatic function: Pugh's classification, indocyanine green, antipyrine, and dextromethorphan.
    Figg WD, Dukes GE, Lesesne HR, Carson SW, Songer SS, Pritchard JF, Hermann DJ, Powell JR, Hak LJ.
    Pharmacotherapy; 1995 Dec 04; 15(6):693-700. PubMed ID: 8602375
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of acute and chronic propranolol administration on antipyrine and paracetamol clearance in patients with chronic liver disease.
    Hayes PC, Bouchier IA.
    Am J Gastroenterol; 1989 Jul 04; 84(7):723-6. PubMed ID: 2741882
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of age on antipyrine metabolism in patients with gastric cancer.
    Higuchi T, Nakamura T, Uchino H.
    J Natl Cancer Inst; 1980 Nov 04; 65(5):897-900. PubMed ID: 6933259
    [Abstract] [Full Text] [Related]

  • 12. [In vivo activity of drug-metabolizing enzymes in various pathological conditions].
    Krakovskiĭ ME, Ashirmetov AKh.
    Vopr Med Khim; 1985 Nov 04; 31(1):76-9. PubMed ID: 3984279
    [Abstract] [Full Text] [Related]

  • 13. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA, Shand DG, Wilkinson GR, Nies AS.
    J Clin Invest; 1974 Apr 04; 53(4):1101-7. PubMed ID: 4205524
    [Abstract] [Full Text] [Related]

  • 14. Disposition of aminopyrine, antipyrine, diazepam, and indocyanine green in patients with liver disease or on anticonvulsant drug therapy: diazepam breath test and correlations in drug elimination.
    Hepner GW, Vesell ES, Lipton A, Harvey HA, Wilkinson GR, Schenker S.
    J Lab Clin Med; 1977 Sep 04; 90(3):440-56. PubMed ID: 894100
    [No Abstract] [Full Text] [Related]

  • 15. Impairment of hepatic drug metabolism in patients with Budd-Chiari syndrome.
    Narang AP, Datta DV, Mathur VS.
    Indian J Med Res; 1982 Apr 04; 75():567-73. PubMed ID: 7106896
    [No Abstract] [Full Text] [Related]

  • 16. [Determination of hepatic metabolic capacity: antipyrine pharmacokinetics in circulatory liver damage due to cardiac insufficiency].
    Kettner W, Banditt P, Walther H.
    Dtsch Z Verdau Stoffwechselkr; 1983 Apr 04; 43(6):255-66. PubMed ID: 6662064
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.